City
Epaper

Vedanta’s Hindustan Zinc logs lower profit & revenue for Q3

By IANS | Updated: January 19, 2024 14:25 IST

Chennai, Jan 19 Vedanta Group’s Hindustan Zinc Ltd closed the third quarter of FY24 with a lower net ...

Open in App

Chennai, Jan 19 Vedanta Group’s Hindustan Zinc Ltd closed the third quarter of FY24 with a lower net profit of Rs 2,028 crore.

In a regulatory filing, the company said it had closed the third quarter ended December 31, 2023 with an operating revenue of Rs 7,067 crore (Q3FY23 Rs 7,628 crore) and a net profit of Rs 2,028 crore (Rs 2,156 crore).

During the period under review, the company’s finance cost went up to Rs 243 crore from Rs 62 crore in the corresponding period the previous year.

The third quarter of FY24 saw the company’s employee benefit expenses, depreciation costs going while power and fuel, mining royalty outgo went down.

At the bourses, Hindustan Zinc shares changed hands for about Rs 318 on Friday after touching a high of Rs 323. The share closed at Rs 311.80 on Thursday.

Disclaimer: This post has been auto-published from an agency feed without any modifications to the text and has not been reviewed by an editor

Open in App

Related Stories

Cricket"Best five-match test series I have ever been part of": Brendon McCullum on Oval Test

InternationalRespect terms of your US visa, authorised period of stay: warns US

CricketSiraj reminded me of Kapil Dev: Former India cricketer Yograj impressed by 'Miyan Magic'

Cricket"Pure Test cricket magic": ICC chairman Jay Shah hails IND-ENG for The Oval classic, praises star performers

CricketEngland's 'Bazball' fails against India, Australia: Time for a rest ahead of Ashes?

Business Realted Stories

BusinessKarti Chidambaram backs India's firm rebuttal to Trump's tariff move

BusinessTrump threatens to 'substantially' raise tariffs on India for buying Russian oil 

BusinessTrump threatens to substantially raise tariff on India over Russian oil purchase

BusinessAdoption of EV in India slower than leading countries like US, EU, China: NITI Aayog report

BusinessAurobindo Pharma’s Q1 net profit falls 10 pc to Rs 824 crore